Does BUPROPION HYDROBROMIDE Cause Polycystic ovaries? 43 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Polycystic ovaries have been filed in association with BUPROPION HYDROBROMIDE (Aplenzin). This represents 18.3% of all adverse event reports for BUPROPION HYDROBROMIDE.
43
Reports of Polycystic ovaries with BUPROPION HYDROBROMIDE
18.3%
of all BUPROPION HYDROBROMIDE reports
0
Deaths
36
Hospitalizations
How Dangerous Is Polycystic ovaries From BUPROPION HYDROBROMIDE?
Of the 43 reports, 36 (83.7%) required hospitalization.
Is Polycystic ovaries Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BUPROPION HYDROBROMIDE. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does BUPROPION HYDROBROMIDE Cause?
Headache (82)
Asthma (68)
Gastrooesophageal reflux disease (64)
Therapeutic product effect incomplete (61)
Wheezing (59)
Hypertension (55)
Fibromyalgia (46)
Blood test abnormal (45)
Burning sensation (45)
Cardiac disorder (45)
What Other Drugs Cause Polycystic ovaries?
MONTELUKAST (309)
ALBUTEROL (307)
TRAZODONE (304)
APIXABAN (275)
LEVOTHYROXINE (258)
PREDNISONE (252)
CLONAZEPAM (249)
MOMETASONE FUROATE (249)
METOPROLOL (247)
ESOMEPRAZOLE (246)
Which BUPROPION HYDROBROMIDE Alternatives Have Lower Polycystic ovaries Risk?
BUPROPION HYDROBROMIDE vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE
BUPROPION HYDROBROMIDE vs BUPROPION\NALTREXONE
BUPROPION HYDROBROMIDE vs BUROSUMAB
BUPROPION HYDROBROMIDE vs BUROSUMAB-TWZA
BUPROPION HYDROBROMIDE vs BUSPIRONE